BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29324814)

  • 1. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
    Topcagic J; Feldman R; Ghazalpour A; Swensen J; Gatalica Z; Vranic S
    PLoS One; 2018; 13(1):e0191244. PubMed ID: 29324814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable
    Lazo de la Vega L; McHugh JB; Cani AK; Kunder K; Walocko FM; Liu CJ; Hovelson DH; Robinson D; Chinnaiyan AM; Tomlins SA; Harms PW
    Mol Cancer Res; 2017 Nov; 15(11):1551-1557. PubMed ID: 28775129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma.
    Papadaki H; Kounelis S; Kapadia SB; Bakker A; Swalsky PA; Finkelstein SD
    Am J Surg Pathol; 1996 Jun; 20(6):715-21. PubMed ID: 8651351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
    Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
    Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.
    Weiss GJ; Liang WS; Izatt T; Arora S; Cherni I; Raju RN; Hostetter G; Kurdoglu A; Christoforides A; Sinari S; Baker AS; Metpally R; Tembe WD; Phillips L; Von Hoff DD; Craig DW; Carpten JD
    PLoS One; 2012; 7(5):e37029. PubMed ID: 22649506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
    Czapiewski P; Kunc M; Haybaeck J
    Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.
    Wang L; Ding Y; Wei L; Zhao D; Wang R; Zhang Y; Gu X; Wang Z
    Medicine (Baltimore); 2016 May; 95(18):e3536. PubMed ID: 27149458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
    Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
    Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
    Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
    J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted 595-gene genomic profiling demonstrates low tumor mutational burden in olfactory neuroblastoma.
    Friedman J; Schumacher JK; Papagiannopoulos P; Al-Khudari S; Tajudeen BA; Batra PS
    Int Forum Allergy Rhinol; 2021 Jan; 11(1):58-64. PubMed ID: 32558242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Odorant receptor genes are expressed in olfactory neuroblastoma.
    Gonzalez-Kristeller DC; Gutiyama LM; Campos AH; Soares FA; Brentani H; Malnic B
    Genet Mol Res; 2013 Sep; 12(3):3479-87. PubMed ID: 24065686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
    Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
    Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.
    Gatalica Z; Vranic S; Ghazalpour A; Xiu J; Ocal IT; McGill J; Bender RP; Discianno E; Schlum A; Sanati S; Palazzo J; Reddy S; Pockaj B
    Oncotarget; 2016 Jan; 7(2):1707-16. PubMed ID: 26625196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
    Li X; Liu HG; Xie XJ; Han YD; Li M
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.
    Czapiewski P; Kunc M; Gorczyński A; Haybaeck J; Okoń K; Reszec J; Lewczuk A; Dzierzanowski J; Karczewska J; Biernat W; Turri-Zanoni M; Castelnuovo P; Taverna C; Franchi A; La Rosa S; Sessa F; Klöppel G
    Hum Pathol; 2018 Sep; 79():144-150. PubMed ID: 29807052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival.
    Kim JW; Kong IG; Lee CH; Kim DY; Rhee CS; Min YG; Kim CW; Chung JH
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):708-12. PubMed ID: 18984268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
    Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
    Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytogenetic aberrations of esthesioneuroblastoma studied by comparative genomic hybridization].
    You XJ; Petersen I; Arps H; Draf W; Bockmühl U
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):16-21. PubMed ID: 15771791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.
    Czapiewski P; Gorczyński A; Haybaeck J; Okoń K; Reszeć J; Skrzypczak W; Dzierżanowski J; Kunc M; Karczewska J; Biernat W
    Pol J Pathol; 2016 Jun; 67(2):130-5. PubMed ID: 27543867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.
    Gleeson EM; Feldman R; Mapow BL; Mackovick LT; Ward KM; Morano WF; Rubin RR; Bowne WB
    Am J Clin Oncol; 2018 Aug; 41(8):777-783. PubMed ID: 28263231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.